Manzetti S. (2002). Taking the complexity out of protein sequence analysis. Drug Discovery Today, 7:172-175. PDF

Peters J, Chen N, Fowler B, Korsinczky MJL, Manzetti S, Gatton M, Saul A and Cheng Q. (2002). Loss in fitness associated with atovaquone resistance mutations in P. falciparum. Antimicrobial agents and Chemotherapy, 46:2435-2441. PDF

Barnard R, Kelly G, Manzetti S and Harris EL. (2001). Neither GH nor SS/Jr rats have an A1079T
transversion in αNa+, K+-ATPase gene. Hypertension, 38: 786-792. PDF

Manzetti S. and Barnard R. (2001). An analysis of reliability of in silico automated modeling using the
GROMOS96 force field, in prediction of kinetic parameters for trypsin and its substrates. Australian
Biochemistry Society, Combined Abstracts Combio 2001, P-018.

Manzetti S., Clements J., Willemsen N. and Walsh T. (2001). Optimization of purification of His-tagged prokallikreins from an insect cell expression system. Australian Biochemistry Society, Combined Abstracts Combio 2001, P-072

PREVIOUS
 

 

 

   

Recent developments

What is Sanare's activity? Are you in a hurry or looking for a brief explanation of Sanare's activity? Read more...

November 2009: Full studies from Charles River Laboratories, Ann Arbor.
October 2009: International patent survey successful. PCT patenting process to start in 2010. Read more...
 
 
Ongoing Research
- "Identification of twelve non-toxic oligopeptides with cytostatic effects on three breast cancer cell lines."  Read More...

 

 

Copyright © 2007-2008 Sanare A.S.
Sanare A.S. Tinghaugveien 435, 3175 Ramnes. Norway.  Org. nr. 991489029 
Tel: +47 9132 7347 Fax: +47 3339 7855